54 related articles for article (PubMed ID: 1287082)
1. The effect of sulphonylurea therapy on serum total cholesterol and high density lipoprotein cholesterol.
Singh T; Singh S; Bhullar GS
J Indian Med Assoc; 1992 Oct; 90(10):259-61. PubMed ID: 1287082
[TBL] [Abstract][Full Text] [Related]
2. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
3. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Brunner D
Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
[TBL] [Abstract][Full Text] [Related]
4. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
5. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
6. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
7. [Effect of glibenclamide on lipid metabolism in non-insulin-dependent diabetic patients].
Ratzmann KP; Schimke E; Herrmann C; Borngräber G; Meusel K
Z Gesamte Inn Med; 1988 Mar; 43(5):122-4. PubMed ID: 3133890
[TBL] [Abstract][Full Text] [Related]
8. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).
Elkeles RS
Diabete Metab; 1991 May; 17(1 Pt 2):197-200. PubMed ID: 1936476
[TBL] [Abstract][Full Text] [Related]
9. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
Rajmohan L; Deepa R; Mohan A; Mohan V
Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus.
Bhatnagar D; Durrington PN; Kumar S; Mackness MI; Boulton AJ
Diabet Med; 1996 Feb; 13(2):139-44. PubMed ID: 8641118
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin and glibenclamide alone and in combination on serum lipids and lipoproteins in patients with non-insulin-dependent diabetes mellitus.
Hermann LS; Kjellström T; Nilsson-Ehle P
Diabete Metab; 1991 May; 17(1 Pt 2):174-9. PubMed ID: 1936472
[TBL] [Abstract][Full Text] [Related]
12. [Total cholesterol and high-density lipoprotein cholesterol in patients with non-insulin-dependent diabetes mellitus].
Dias CM; Nogueira P; Rosa AV; De Sa JV; Gouvea MF; Marinho Falcao JC
Acta Med Port; 1995 Nov; 8(11):619-28. PubMed ID: 8713507
[TBL] [Abstract][Full Text] [Related]
13. [Effect of insulin therapy on lipoprotein concentrations in secondary sulfonylurea treatment failures in menopause].
Schauer UJ
Z Gesamte Inn Med; 1988 Dec; 43(23):666-9. PubMed ID: 3149825
[TBL] [Abstract][Full Text] [Related]
14. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
Udawat H; Goyal RK
Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
[TBL] [Abstract][Full Text] [Related]
15. Effective reduction of LDL cholesterol by indigenous plant product.
Bhardwaj PK; Dasgupta DJ; Prashar BS; Kaushal SS
J Indian Med Assoc; 1994 Mar; 92(3):80-1. PubMed ID: 8057004
[TBL] [Abstract][Full Text] [Related]
16. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
17. High density lipoprotein changes during treatment of diabetic ketoacidosis.
Joven J; Rubiés-Prat J; de la Figuera M; Valdés M; Villabona CM; Chacón P; Masdeu S
Diabete Metab; 1985 Apr; 11(2):102-5. PubMed ID: 3924672
[TBL] [Abstract][Full Text] [Related]
18. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
Temelkova-Kurktschiev T; Hanefeld M
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
[TBL] [Abstract][Full Text] [Related]
19. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
Gudat U; Bungert S; Kemmer F; Heinemann L
Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
[TBL] [Abstract][Full Text] [Related]
20. Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy.
Mohan R; Mohan V; Susheela L; Ramachandran A; Viswanathan M
Acta Diabetol Lat; 1984; 21(1):85-9. PubMed ID: 6730849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
